IL43851A - Radiological contrast media comprising barium titanate and/or barium zirconate - Google Patents
Radiological contrast media comprising barium titanate and/or barium zirconateInfo
- Publication number
- IL43851A IL43851A IL43851A IL4385173A IL43851A IL 43851 A IL43851 A IL 43851A IL 43851 A IL43851 A IL 43851A IL 4385173 A IL4385173 A IL 4385173A IL 43851 A IL43851 A IL 43851A
- Authority
- IL
- Israel
- Prior art keywords
- barium
- ray contrast
- contrast medium
- patient
- sulphate
- Prior art date
Links
- 239000002872 contrast media Substances 0.000 title claims abstract 20
- JRPBQTZRNDNNOP-UHFFFAOYSA-N barium titanate Chemical compound [Ba+2].[Ba+2].[O-][Ti]([O-])([O-])[O-] JRPBQTZRNDNNOP-UHFFFAOYSA-N 0.000 title claims abstract 7
- 229910002113 barium titanate Inorganic materials 0.000 title claims abstract 7
- 229910021523 barium zirconate Inorganic materials 0.000 title claims abstract 6
- DQBAOWPVHRWLJC-UHFFFAOYSA-N barium(2+);dioxido(oxo)zirconium Chemical compound [Ba+2].[O-][Zr]([O-])=O DQBAOWPVHRWLJC-UHFFFAOYSA-N 0.000 title claims abstract 6
- 229940039231 contrast media Drugs 0.000 title abstract 2
- 235000012054 meals Nutrition 0.000 claims abstract 8
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims abstract 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract 5
- 229910052788 barium Inorganic materials 0.000 claims abstract 5
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims abstract 5
- 231100000252 nontoxic Toxicity 0.000 claims abstract 5
- 230000003000 nontoxic effect Effects 0.000 claims abstract 5
- 229910021653 sulphate ion Inorganic materials 0.000 claims abstract 5
- 239000007900 aqueous suspension Substances 0.000 claims abstract 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims abstract 4
- 239000003381 stabilizer Substances 0.000 claims abstract 4
- PMZURENOXWZQFD-UHFFFAOYSA-L sodium sulphate Substances [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract 3
- 229920001817 Agar Polymers 0.000 claims abstract 2
- 239000001856 Ethyl cellulose Substances 0.000 claims abstract 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims abstract 2
- 108010010803 Gelatin Proteins 0.000 claims abstract 2
- 241000206672 Gelidium Species 0.000 claims abstract 2
- 229920000084 Gum arabic Polymers 0.000 claims abstract 2
- 241000978776 Senegalia senegal Species 0.000 claims abstract 2
- 239000000205 acacia gum Substances 0.000 claims abstract 2
- 235000010489 acacia gum Nutrition 0.000 claims abstract 2
- 235000010419 agar Nutrition 0.000 claims abstract 2
- 239000001175 calcium sulphate Substances 0.000 claims abstract 2
- 235000011132 calcium sulphate Nutrition 0.000 claims abstract 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims abstract 2
- 229920001249 ethyl cellulose Polymers 0.000 claims abstract 2
- 239000008273 gelatin Substances 0.000 claims abstract 2
- 229920000159 gelatin Polymers 0.000 claims abstract 2
- 235000019322 gelatine Nutrition 0.000 claims abstract 2
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract 2
- 229920000609 methyl cellulose Polymers 0.000 claims abstract 2
- 239000001923 methylcellulose Substances 0.000 claims abstract 2
- 235000010981 methylcellulose Nutrition 0.000 claims abstract 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims abstract 2
- 235000011152 sodium sulphate Nutrition 0.000 claims abstract 2
- 239000000725 suspension Substances 0.000 claims 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 159000000009 barium salts Chemical class 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 229910052939 potassium sulfate Inorganic materials 0.000 abstract 1
- 239000001120 potassium sulphate Substances 0.000 abstract 1
- 235000011151 potassium sulphates Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7245166A FR2210391B1 (enrdf_load_stackoverflow) | 1972-12-19 | 1972-12-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL43851A0 IL43851A0 (en) | 1974-03-14 |
| IL43851A true IL43851A (en) | 1976-09-30 |
Family
ID=9108915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL43851A IL43851A (en) | 1972-12-19 | 1973-12-18 | Radiological contrast media comprising barium titanate and/or barium zirconate |
Country Status (19)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3316703A1 (de) * | 1983-05-04 | 1984-11-08 | Schering AG, 1000 Berlin und 4709 Bergkamen | Orales kontrastmittel fuer die kernspintomographie und dessen herstellung |
| US5407659A (en) * | 1991-10-22 | 1995-04-18 | Mallinckrodt Medical, Inc. | Treated calcium/oxyanion-containing particles for medical diagnostic imaging |
-
1972
- 1972-12-19 FR FR7245166A patent/FR2210391B1/fr not_active Expired
-
1973
- 1973-12-07 DE DE2361143A patent/DE2361143C3/de not_active Expired
- 1973-12-11 BE BE138758A patent/BE808506A/xx not_active IP Right Cessation
- 1973-12-12 NL NLAANVRAGE7317012,A patent/NL171860C/xx not_active IP Right Cessation
- 1973-12-13 AT AT1046373A patent/AT333946B/de not_active IP Right Cessation
- 1973-12-17 GB GB5833573A patent/GB1456230A/en not_active Expired
- 1973-12-18 SE SE7317066A patent/SE398969B/xx unknown
- 1973-12-18 FI FI3891/73A patent/FI55295C/fi active
- 1973-12-18 IL IL43851A patent/IL43851A/en unknown
- 1973-12-18 DK DK685873AA patent/DK133770B/da not_active IP Right Cessation
- 1973-12-18 IN IN2754/CAL/1973A patent/IN142841B/en unknown
- 1973-12-18 ES ES421584A patent/ES421584A1/es not_active Expired
- 1973-12-19 HU HUTA1286A patent/HU168697B/hu unknown
- 1973-12-19 OA OA55083A patent/OA04677A/xx unknown
- 1973-12-19 LU LU69033A patent/LU69033A1/xx unknown
- 1973-12-19 JP JP14292573A patent/JPS5325012B2/ja not_active Expired
- 1973-12-19 CH CH1778873A patent/CH585557A5/xx not_active IP Right Cessation
- 1973-12-19 NO NO4862/73A patent/NO139946C/no unknown
- 1973-12-19 IE IE2300/73A patent/IE38662B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE842009L (en) | Improved barium sulfate for use as a radiographic contrast¹agent | |
| KR940005636A (ko) | 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 수화물 결정 및 이들의 제조방법 | |
| LU88361I2 (fr) | Excenel | |
| GB1214776A (en) | Process for manufacturing nitrocellulose granules | |
| IE39281B1 (en) | Compisitions for radiographic scanning | |
| GB1417003A (en) | Stabilisation of fibrinogen | |
| IL55186A (en) | Crystalline form of the sodium salt of 3-acetoxymethyl 7 (2 2-amino 4-thiazolyl) 2-methoxy- imino acetamido) ceph-3eme 4carboxylic acid syn isomer, process for preparing it and the pharmaceutical compsotions containing it | |
| GB1530106A (en) | Stannous pyrophosphate technetium-99m compositions | |
| MX166069B (es) | Procedimiento para producir proinsulina humana cristalina | |
| IL43851A (en) | Radiological contrast media comprising barium titanate and/or barium zirconate | |
| BG48923A3 (bg) | Метод за получаване на инжекционен разтвор на окситетрациклин | |
| IE38750B1 (en) | 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacetamido) desacetoxycephalosporanic acid dihydrate | |
| IE44339L (en) | Piperazine derivatives. | |
| GB1289283A (enrdf_load_stackoverflow) | ||
| GB1443786A (en) | Compositions having bactericidal and sporicidal activity | |
| GB1471326A (en) | Corticosteroid phosphate salts/neomycin sulphate ophthalmic solution | |
| GB1283185A (en) | Manufacture of levulinic acid | |
| ES427653A1 (es) | Procedimiento para la preparacion de nuevos acidos 3-hidro- xiacilaminometil-5-acilamino-2, 4, 6-triyodo-benzoicos. | |
| CH611602A5 (en) | Process for the preparation of (N-ethyl-2-pyrrolidino)methylamine derivatives | |
| GB1362276A (en) | Stable lactone solution | |
| GB1450524A (en) | 2,4,6-triiodo-5-methoxyacetamido-n-methylisophthalamic acid and salts acyl halides and esters thereof | |
| GB1313164A (en) | Blood plasma substitute | |
| GB1162247A (en) | Cephalosporanic Acid Derivatives and a Process for the Preparation thereof | |
| ES443034A1 (es) | Procedimiento para la aplicacion de una capa molecular de a-cido aminofosfonico sobre dihidrato de hidrogenofosfato de calcio. | |
| US2635980A (en) | Stabilized sulfa drug |